Tesirine SG3249 is a potent antibody-drug conjugate (ADC) molecule developed by Seagen Inc. It serves as a potential therapy for the treatment of multiple types of cancer. Tesirine is still under clinical investigation to determine its outcomes for therapy. The drug is made up of a monoclonal antibody that is linked to a small molecule payload, which is responsible for its potent anti-cancer properties. The drug is in high demand due to its effectiveness in killing cancer cells, especially those that are resistant to chemotherapy. This article intends to shed more light on the Tesirine SG3249.
Chemical Name
The chemical name of Tesirine SG3249 is (2R,3R)-3-((1R)-3-(3-((3-(dimethylamino)propyl)thioureido)-1-methyl-1-oxobutyl)-1-oxo-2-(2-(2-pyridinyl)ethoxy)propyl)-2-hydroxy-2-methylpropanamide.
Molecular Formula
The molecular formula of Tesirine SG3249 is C31H46N6O6S.
Formula Weight
The formula weight of Tesirine SG3249 is 634.8.
CAS NO.
The CAS number of Tesirine SG3249 is 1595275-62-9.
Top Ten Keywords
Synonyms
Some synonyms of Tesirine SG3249 include:
Health Benefits of Tesirine SG3249
Tesirine SG3249 is a promising therapy for the treatment of cancer. Its anti-cancer properties make it potent in the treatment of multiple types of cancer. It functions by binding to specific cancer cells and delivering a toxic payload that kills them. This drug has shown positive effects in preclinical and clinical studies. Tesirine SG3249 targets cells that express a particular antigen on their surface, which is indicative of certain types of tumors. The therapy is well tolerated, and its use can lead to significant tumor reduction.
Potential Effects
Tesirine SG3249 has several potential effects, including:
Product Mechanism
Tesirine SG3249 is an ADC that functions by binding to specific cancer cells through a monoclonal antibody. Once the drug has identified a cancer cell, it delivers a potent small molecule payload that causes the cell to die. The drug is designed to be effective in treating cancers that have become resistant to chemotherapy.
Safety
Tesirine SG3249 is generally safe and well-tolerated. However, as with all drugs, some safety precautions should be taken. Certain individuals may be more susceptible to adverse reactions than others, including those with kidney or liver dysfunction. It is important to consult a healthcare provider before starting Tesirine SG3249 therapy.
Side Effects
The side effects of Tesirine SG3249 may vary from person to person. Some side effects include:
Dosing Information
Tesirine SG3249 is administered intravenously once every three weeks. The dosage is based on factors such as body weight and overall medical condition. The treating healthcare provider should decide the appropriate dose.
Conclusion
Tesirine SG3249 is a promising ADC therapy for the treatment of multiple types of cancer. The drug is still under clinical investigation to determine its potential outcomes. Its potency is attributed to its ability to target specific cancer cells and deliver a toxic payload that causes their death
